Company Profile
Vivani Medical Stock Price, News & Analysis
Company overview
Business overview
Vivani Medical is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Vivani Medical is followed within the medical devices universe for its exposure to procedure trends and reimbursement support.
Business Model Characteristics
Vivani Medical makes its case through product adoption, operating discipline, and the pace at which the installed base turns into recurring revenue.
Position Within the Biotechnology Landscape
Compared with drug-development peers, Vivani Medical trades more like a product-adoption story, where reimbursement, procedure volume, and refresh cycles matter more than a single clinical binary.
Why the stock is moving
VANI is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Vivani is now clearly leaning on NPM-139, the semaglutide implant program. The planned Phase 1 feasibility study in Australia is the next obvious step, and the manufacturing upgrades matter because they show the company is already thinking about what comes after the first clinical readout.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off
Source: Vivani Medical
- 02
Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025
Source: Vivani Medical
- 03
Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results
Source: Vivani Medical
- 04
- 05
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
Source: Vivani Medical
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.